Programmed cell death-1, or PD-1, has become a headline-grabbing molecule best known for its role in cancer immunotherapies ...
The risks of adverse effects and complications from treatment for prostate cancer are substantial and continue for years after treatment ends.
Ultimately, the research showed that immune cells need physical as well as chemical cues to properly manage PD-1 activity, ...
Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSEâ„¢ Platform for the treatment of drug ...